Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.

Sign up for a 7-day FREE trial today!

Latest News in Intellectual Property

• February 06, 2026

  Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit

  Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.

• February 06, 2026

  OpenAI Can Keep Atty Comms Secret After All, Judge Says

  A New York federal judge Friday set aside a magistrate judge's order requiring OpenAI's in-house attorneys to share their internal communications regarding deleted training datasets with authors suing over alleged copyright infringement, holding that the conclusions underlying that decision were "clearly erroneous or contrary to law."

• February 06, 2026

  HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight

  U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.

• February 06, 2026

  Squires Rules Inconsistent Claim Constructions Doom 3 IPRs

  U.S. Patent and Trademark Office Director John Squires has undone three decisions by the Patent Trial and Appeal Board instituting inter partes reviews, finding that the patent challengers made conflicting claim construction arguments in the reviews and in court.

• February 06, 2026

  'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.

  D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.

See more Intellectual Property news